Evaluation of the impact of hemotransfusion on hospitalization length and complications in patients with non-variceal upper gastrointestinal bleeding

Authors

  • Joao Felipe Bernardi Lora
  • Jean Rodrigo Tafarel
  • Maria Julia de Moraes Campos Roth
  • Rafaella Stradiotto Bernardelli

DOI:

https://doi.org/10.34119/bjhrv6n6-109

Keywords:

upper gastrointestinal bleeding, blood transfusion, clinical severity, rebleeding, hospitalization length

Abstract

Background: Upper gastrointestinal bleeding (UGB) is a common emergency associated with high morbidity and mortality. It can be caused by various factors, including peptic ulcers and vascular lesions. The decision to perform blood transfusion in stable UGB patients is still controversial, with more restrictive strategies showing better outcomes. Methods: A retrospective cohort study reviewed 1433 medical records of non-variceal UGB patients in a Brazilian tertiary care setting. Patients were divided into groups based on whether they received blood transfusion or not. Patient characteristics, laboratory values, procedures, and outcomes were analyzed. Logistic and linear regression models were used to assess the association of blood transfusion with complications and hospital stay. Results: Blood transfusion was associated with increased hospitalization length (p<0.001), higher rebleeding rates (p<0.001), and greater clinical severity. However, no association with worse renal outcomes was observed (p=0.203). Adjusting for clinical severity (Glasgow-Blatchford score) reduced the significance of the association with hospitalization length. Conclusion: Blood transfusion in stable UGB patients may serve as a marker of severity, associated with longer hospital stay and increased rebleeding rates. It does not appear to have a direct causal relationship with worse renal outcomes. The study suggests that clinical severity may play a pivotal role in outcomes, as indicated by the association with Glasgow-Blatchford score.

References

Betés M, Muñoz-Navas M. Nonvariceal Upper Gastrointestinal Bleeding. Medicine - Programa de Formación Médica Continuada Acreditado. 2016;12(2):82-91.

Villanueva C, Colomo A, Bosch A, Concepción M, Hernandez-Gea V, Aracil C, et al. Transfusion strategies for acute upper gastrointestinal bleeding. [SUPPLEMENTARY APPENDIX]. N Engl J Med [Internet]. 2013;368(1):11– 21

Gralnek IM, Barkun AN, Bardou M. Management of acute bleeding from a peptic ulcer. N Engl J Med. 2008 Aug 28;359(9):928-37. doi: 10.1056/NEJMra0706113. PMID: 18753649.

Barkun A, Almadi M, Kuipers E, Laine L, Sung J, Tse F et al. Management of Nonvariceal Upper Gastrointestinal Bleeding: Guideline Recommendations From the International Consensus Group. Annals of Internal Medicine. 2019;171(11):805.

Samuel R, Bilal M, Tayyem O, Guturu P. Evaluation and management of Non-variceal Upper gastrointestinal bleeding. Disease-a-Month [Internet]. 2018;64(7):333–43

Kumar NL, Nayor J, Saltzman JR. Initial management of nonvariceal upper gastrointestinal bleeding and timing of endoscopy. Tech Gastrointest Endosc [Internet]. 2016;18(4):170–6.

Mearin F, Lanas A, Al E. Open questions and misconceptions in the diagnosis and management of anemia in patients with gastrointestinal bleeding. Gastroenterol Hepatol [Internet]. 2017;33(7): 484–9

Tokar JL, Higa JT. Acute Gastrointestinal Bleeding. Ann Intern Med. 2022 Feb;175(2): ITC17-ITC32. doi 10.7326/AITC202202150. Epub 2022 Feb 8. PMID: 35130044.

Roberts I, Evans P, Bunn F, Kwan I, Crowhurst E. Is the normalization of blood pressure in bleeding trauma patients harmful? Lancet 2001;357:385-7.

Duggan JM. Transfusion in gastrointestinal hemorrhage — if, when, and how much? Aliment Pharmacol Ther 2001;15: 1109-13.

Taha AS, McCloskey C, Craigen T, Angerson WJ, Shah AA, Morran CG. Mortality following blood transfusion for non-variceal upper gastrointestinal bleeding. Frontline Gastroenterol. 2011 Oct;2(4):218-225. doi 10.1136/fg.2011.004572. Epub 2011 Jul 16. PMID: 28839613; PMCID: PMC5517239.

Klebl F, Bregenzer N, Schöfer L, Tamme W, Langgartner J, Schölmerich J, Messmann H. Risk factors for mortality in severe upper gastrointestinal bleeding. Int J Colorectal Dis. 2005 Jan;20(1):49-56. doi 10.1007/s00384-004-0624-2. Epub 2004 Aug 19. PMID: 15322836.

Le Jeune IR, Gordon AL, Farrugia D, Manwani R, Guha IN, James MW. Safe discharge of patients with low-risk upper gastrointestinal bleeding (UGIB): can the use of Glasgow-Blatchford Bleeding Score be extended? Acute Med. 2011;10(4):176-81. PMID: 22111089.

Villanueva C, Colomo A, Bosch A, Concepción M, Hernandez-Gea V, Aracil C, Graupera I, Poca M, Alvarez-Urturi C, Gordillo J, Guarner-Argente C, Santaló M, Muñiz E, Guarner C. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med. 2013 Jan 3;368(1):11-21. doi: 10.1056/NEJMoa1211801. Erratum in: N Engl J Med. 2013 Jun 13;368(24):2341. PMID: 23281973.

Restellini S, Kherad O, Jairath V, Martel M, Barkun AN. Red blood cell transfusion is associated with increased rebleeding in patients with nonvariceal upper gastrointestinal bleeding. Aliment Pharmacol Ther. 2013 Feb;37(3):316-22. doi 10.1111/apt.12170. Epub 2012 Dec 3. PMID: 23205554.

Downloads

Published

2023-11-15

How to Cite

Lora, J. F. B., Tafarel, J. R., Roth, M. J. de M. C., & Bernardelli, R. S. (2023). Evaluation of the impact of hemotransfusion on hospitalization length and complications in patients with non-variceal upper gastrointestinal bleeding. Brazilian Journal of Health Review, 6(6), 27910–27921. https://doi.org/10.34119/bjhrv6n6-109

Issue

Section

Original Papers